The overwhelming majority of oropharyngeal cancers are attributable to tobacco. However, despite the significant decline in all types of tobacco use since 1965, the incidence of oropharyngeal cancers has been increasing steadily since 1973 and the age at diagnosis is becoming younger in the US. Similar trends are observed in many parts of the world. This presentation will discuss the evidence supporting the roles of chronic inflammation and HPV infection on oropharyngeal cancers as well as their interactions with smoking.

 

Benefits of Attending

This course will provide concise background about emerging new risk factors of oropharyngeal cancers.

 

Course Objectives

At the completion of the program, you should be able to:

 

1. Discuss the roles of HPV infection and chronic inflammation on oropharyngeal cancer
2. Answer questions from your patients and give recommendations
3. Improve your skills on diagnosis and treatment planning
   

Intended Audience: Dentists (both general practitioners and specialists), hygienists and dental assistants need to be familiar with this topic to educate their patients and to provide appropriate care.

UB Faculty Presenter:

Mine Tezal, DDS, PhD, Assistant Professor, Department of Oral Diagnostic Sciences, University at Buffalo, NYS Center of Excellence in Bioinformatics and Life Sciences.

She is also a research scientist in the Department of Dentistry and Maxillofacial Prosthetics at Roswell Park Cancer Institute.

6-9pm, Wednesday night  (3 CE Credit Hrs ADA/CERP)
UB Health Science Library/Abbot Hall, South Campus Directions